The American Heart Association 2030 Impact Goal: A Presidential Advisory From the American Heart Association

Abstract

Each decade, the American Heart Association (AHA) develops an Impact Goal to guide its overall strategic direction and investments in its research, quality improvement, advocacy, and public health programs. Guided by the AHA's new Mission Statement, to be a relentless force for a world of longer, healthier lives, the 2030 Impact Goal is anchored in an understanding that to achieve cardiovascular health for all, the AHA must include a broader vision of health and well-being and emphasize health equity. In the next decade, by 2030, the AHA will strive to equitably increase healthy life expectancy beyond current projections, with global and local collaborators, from 66 years of age to at least 68 years of age across the United States and from 64 years of age to at least 67 years of age worldwide. The AHA commits to developing additional targets for equity and well-being to accompany this overarching Impact Goal. To attain the 2030 Impact Goal, we recommend a thoughtful evaluation of interventions available to the public, patients, providers, healthcare delivery systems, communities, policy makers, and legislators. This presidential advisory summarizes the task force's main considerations in determining the 2030 Impact Goal and the metrics to monitor progress. It describes the aspiration that these goals will be achieved by working with a diverse community of volunteers, patients, scientists, healthcare professionals, and partner organizations needed to ensure success.

Keywords: AHA Scientific Statements; goals; health equity; healthy aging; life expectancy; prevention and control; public health.

Figure 1.. Increasing Health-Adjusted Life Expectancy (HALE).

HALE is the number of years living in good health, accounting for years lived with disease or disability and years lost due to premature death. As shown, HALE can be increased through improving health and well-being, preventing or delaying onset and severity of disease, and increasing life expectancy.

Figure 2.. Comparison of GBD (Global Burden of Diseases, Injuries, and Risk Factors Study) mortality rank order in 2007 and 2017 in the United States, by causes and risk factors.

CKD indicate chronic kidney disease; inj, injury; LDL, low-density lipoprotein; and TB, tuberculosis.

Figure 3.. Forecast for US healthy life expectancy, 2018 to 2030.

Error bars represent 95% uncertainty intervals.

Figure 4.. US health-adjusted life expectancy forecast and goal.

Error bars represent 95% uncertainty intervals.

Figure 5.. Forecast of global HALE, 1990 to 2030.

Error bars represent 95% uncertainty intervals. HALE indicates health-adjusted life expectancy.

Figure 6.. Global health-adjusted life expectancy forecast and goal.

Error bars represent 95% uncertainty intervals.

Figure 7.. Health-adjusted life expectancy (HALE)* across all US states, 2017.

*HALE <1 year of age.

Figure 8.. 2017 global average health-adjusted life expectancy grouped by World Bank income group.

Figure 9.. People’s perception of their well-being, United States, 2017.

Figure 10.. Correlation of perceived well-being and cardiovascular health.

Rates of cardiovascular risk factors, disease, and health by overall well-being score. Q1=lowest well-being; Q5= highest well-being. AMI indicates acute myocardial infarction; CHD, congestive heart disease; CV, cardiovascular; and CVD, cardiovascular disease. Adapted from Spatz et al. Copyright © 2014, American Heart Association, Inc.